• search

Russia to produce anti-HIV drugs next year : Offcial

Written by: Staff

Moscow, May 4 (UNI) Russia will start producing generic versions of patented anti-retroviral drugs for treating HIV, early next year.

''We will begin producing the basic range of anti-HIV drugs in Russia, as early as 2007,'' Ramil Khabriyev, head of the Federal Service for the Supervision of Public Health and Social Affairs said in an interview to the Rossiiskaya Gazeta newspaper, published today.

Mr Khabriyev said Russia's health authorities were currently negotiating the launch of production with several Western pharmaceutical companies.

''A whole number of foreign producers have already begun to inspect our pharmaceutical factories with a view to launching licensed production,'' he said, adding that domestic production would make anti-retrovirals more affordable to Russian HIV/AIDS patients.

According to government statistics, about 350,000 people are suffering from HIV/AIDS in Russia.

However, UN experts have said the real number is 1.4 million, with more than 80 percent of HIV-positive Russians aged under 30.

Russian President Vladimir Putin said last week that at Russia's initiative, AIDS problem will be included in the agenda of the summit of G-8 leaders, to be held in St Petersburg in mid-July, as it was a major concern of the international community.

He also called for drafting a long-term strategy to fight against AIDS and its effects.

''In drafting a programme for five years to come it is necessary to include in it again measures for preventing HIV infection from spreading,'' Mr Putin stressed.


For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more